Restoring Veeva Systems to Watch List

With Q1 sales growth of almost 24%, Veeva has returned to the Green Screens and will return to the Watch List as well. This specialized pharmaceutical SaaS provider continues to have an outstanding economic moat, and growth is re-accelerating after a few slow years. My fair value estimate is $186. The stock trades a touch below that at present, making this one a close watch for Buy List addition in the near future.

Watch List

RDDT 7.71%
NTNX 31.52%
CRWD 63.06%
SE 29.38%
SNOW 7.59%
APPF 4.88%
PINS -23.24%

Buy List

SEMR -38.26%
TSM -38.57%
GOOG -51.98%
NYAX -58.66%
MSFT -31.00%
ODD -31.84%
ASR -28.02%
FLYW -38.06%
HRMY -54.53%
YOU -35.24%
ABNB -32.20%
MELI -29.43%
ADBE -40.48%

Hold List

VTEX -18.40%
ZETA -23.56%
CELH 34.60%
TOST 11.93%
CPNG -15.62%
HIMS -16.74%
PAYC -21.31%
MNDY 6.93%
GLBE -22.43%
ZS 27.08%
V -5.03%
ADSK -3.10%
NOW -3.65%
FTNT -5.29%
TEAM -4.39%